Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Rosenbaum

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Public Health Ethics|October 17, 2024
Psychedelics in PERIL: The Commercial Determinants of Health, Financial Entanglements and Population Health EthicsDaniel Buchman, Daniel Rosenbaum
Current Hypertension Reports|July 16, 2009
Choosing the ideal drug for hypertension after ischemic strokeEduard Rozner, Arnold Eggers, Daniel Rosenbaum
Healthcare Policy = Politiques De Sante|July 24, 2023
Commentary: Access to Psychedelics for Psychological Suffering at the End of Life - Prioritizing Our PrioritiesDaniel Rosenbaum, Sarah Hales, Daniel Z Buchman
Remote Sensing|August 27, 2020
US EPA EnviroAtlas Meter-Scale Urban Land Cover (MULC): 1-m Pixel Land Cover Class Definitions and GuidanceAndrew Pilant, Keith Endres, Daniel Rosenbaum, et al.
Pediatric Radiology|March 22, 2012
Visualization of the normal appendix with MR enterography in childrenArzu Kovanlikaya, Daniel Rosenbaum, Madhu Mazumdar, et al.
Journal of Pediatric Surgery|January 31, 2026
Print, Plan, Perform: Evaluating the Clinical Impact of Anatomical Modelling in the Surgical Treatment of Pediatric Thoracic and Abdominal TumoursShaily Brahmbhatt, Sima Zakani, Eric Greaney, et al.
Omega|July 10, 2025
The Use of Psychedelics for Grief Following Death due to Advanced Illness: A Scoping ReviewDaniel Rosenbaum, Celina Carter, Brandon A Cirella, et al.
Clinical Imaging|December 15, 2018
Normal axillary thickness thresholds as a metric for nutritional status of childrenAlissa L Wall Kleinhenz, Jing Gao, Arzu Kovanlikaya, et al.
Journal of Psychopharmacology (Oxford, England)|February 29, 2020
Microdosing psychedelics: Demographics, practices, and psychiatric comorbiditiesDaniel Rosenbaum, Cory Weissman, Thomas Anderson, et al.
The Hastings Center Report|August 8, 2024
Experiential Training in Psychedelic-Assisted Therapy: A Risk-Benefit AnalysisDaniel Rosenbaum, Crystal Hare, Emma Hapke, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Public Health Ethics|October 17, 2024
Psychedelics in PERIL: The Commercial Determinants of Health, Financial Entanglements and Population Health EthicsDaniel Buchman, Daniel Rosenbaum
Current Hypertension Reports|July 16, 2009
Choosing the ideal drug for hypertension after ischemic strokeEduard Rozner, Arnold Eggers, Daniel Rosenbaum
Healthcare Policy = Politiques De Sante|July 24, 2023
Commentary: Access to Psychedelics for Psychological Suffering at the End of Life - Prioritizing Our PrioritiesDaniel Rosenbaum, Sarah Hales, Daniel Z Buchman
Remote Sensing|August 27, 2020
US EPA EnviroAtlas Meter-Scale Urban Land Cover (MULC): 1-m Pixel Land Cover Class Definitions and GuidanceAndrew Pilant, Keith Endres, Daniel Rosenbaum, et al.
Pediatric Radiology|March 22, 2012
Visualization of the normal appendix with MR enterography in childrenArzu Kovanlikaya, Daniel Rosenbaum, Madhu Mazumdar, et al.
Journal of Pediatric Surgery|January 31, 2026
Print, Plan, Perform: Evaluating the Clinical Impact of Anatomical Modelling in the Surgical Treatment of Pediatric Thoracic and Abdominal TumoursShaily Brahmbhatt, Sima Zakani, Eric Greaney, et al.
Omega|July 10, 2025
The Use of Psychedelics for Grief Following Death due to Advanced Illness: A Scoping ReviewDaniel Rosenbaum, Celina Carter, Brandon A Cirella, et al.
Clinical Imaging|December 15, 2018
Normal axillary thickness thresholds as a metric for nutritional status of childrenAlissa L Wall Kleinhenz, Jing Gao, Arzu Kovanlikaya, et al.
Journal of Psychopharmacology (Oxford, England)|February 29, 2020
Microdosing psychedelics: Demographics, practices, and psychiatric comorbiditiesDaniel Rosenbaum, Cory Weissman, Thomas Anderson, et al.
The Hastings Center Report|August 8, 2024
Experiential Training in Psychedelic-Assisted Therapy: A Risk-Benefit AnalysisDaniel Rosenbaum, Crystal Hare, Emma Hapke, et al.
Pageof 2